“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny
March 19, 2024
PRESS RELEASE: On March 15, 2024, a new research perspective was published by Mikhail V. Blagosklonny M.D., Ph.D., in Oncotarget, entitled, “From osimertinib to preemptive combinations.” continue reading »